intervenciones en el control de la xerostomia en persona en situación paliativa

revisión de alcance

Autores/as

  • Marisa Lourenço Nursing School of Porto - Porto – Portugal, Center for Health Technology and Services Research (CINTESIS) https://orcid.org/0000-0001-5953-788X
  • Sara Cunha Coimbra Hospital and University Center, Intrahospital Support Team in Palliative Care, Coimbra, Portugal https://orcid.org/0000-0001-7726-3907
  • Olga Fernandes Nursing School of Porto - Porto – Portugal, Center for Health Technology and Services Research (CINTESIS https://orcid.org/0000-0002-2134-430X
  • Patricia Silva Coimbra Hospital and University Center, Blood and Transfusion Medicine Service, Coimbra, Portugal https://orcid.org/0000-0003-4165-7044
  • Sandra Oliveira Coimbra Hospital and University Center, Blood and Transfusion Medicine Service, Coimbra, Portugal https://orcid.org/0000-0002-5280-0427

DOI:

https://doi.org/10.29352/mill0218.26797

Palabras clave:

xerostomía, boca seca, cuidados paliativos, intervenciones

Resumen

Introducción: La xerostomía es la sensación subjetiva de boca seca, ocurre cuando se secreta menos saliva que la cantidad de agua perdida por evaporación y absorción de la mucosa ora. Tiene múltiples consecuencias para la salud general y bucal de las personas en situaciones paliativas, y calidad de vida.

Objetivo: Examinar y mapear las intervenciones implementadas para aliviar la xerostomia de la persona en condiciones paliativas. Métodos: Revisión del alcance de acuerdo con los pasos proporcionados por el Instituto Joanna Briggs. Las bases de datos para la investigación fueron: CINAHL COMPLETE®, PUBMED®, MEDLINE COMPLETE®, SCOPUS® y SciELO®

Resultados: Se identificaron 707 artículos, 19 de ellos para el análisis final. Esta revisión consideró los estudios centrados en personas con enfermedad crónica avanzada e irreversible, en situación paliativa y al final de la vida, de 18 años más. Las intervenciones para el control de la xerostomía son: no farmacológicas, evaluación de la cavidad oral, acupuntura, sustitutos de la saliva, estimulantes de la saliva y programas de educación en higiene bucal; parasimpaticomiméticos farmacológicos: pilocarpina y cloruro de betanecol.

Conclusión: La xerostomía es una condición de salud que puede causar vergüenza social y malestar crónico, con un gran impacto en la calidad de vida de las personas. Agrupar la evidencia disponible, dentro de esta temática, puede ayudar a los profesionales de la salud a incorporarla a la práctica asistencial, contribuyendo al aumento de la calidad de vida de la persona y al alivio del sufrimiento.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Sara Cunha, Coimbra Hospital and University Center, Intrahospital Support Team in Palliative Care, Coimbra, Portugal

Coimbra Hospital and University Center, Intrahospital Support Team in Palliative Care, Coimbra, Portugal

Olga Fernandes, Nursing School of Porto - Porto – Portugal, Center for Health Technology and Services Research (CINTESIS

Postdoctorado, Doctor, Enfermero, es profesor coordinador del Máster en Cuidados Paliativos de la Escuela de Enfermería de Oporto y miembro del Grupo de Investigación NursID, Centro de Investigación en Tecnologías y Servicios de Salud de la Facultad de Medicina de la Universidad de Oporto, Portugal.

Citas

Al-Shahri, M. Z., Eldali, A. M., & Al-Zahrani, O. (2012). Nonpain symptoms of new and follow-up cancer patients attending a palliative care outpatient clinic in Saudi Arabia. Indian Journal of Palliative Care, 18(2), 98-102. doi:10.4103/0973-1075.100822

Barford, K. L., & D’Olimpio, J. T. (2008). Symptom management in geriatric oncology: Practical treatment considerations and current challenges. Current Treatment Options in Oncology, 9(2–3), 204–214. https://doi.org/10.1007/s11864-008-0062-4

Crogan N.L. (2015). Relieving Drug-Induced Xerostomia with Sorbet. Annals of Long-Term Care (23)2, https://www.hmpgloballearningnetwork.com/

Davies, A. N. (1997). The management of xerostomia: A review. European Journal of Cancer Care, 6(3), 209–214. https://doi.org/10.1046/j.1365-2354.1997.00036.x

Davies, A. N. (2000). A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliative Medicine, 14(3), 197–203. https://doi.org/10.1191/026921600672294077

Davies, A., Bagg, J., Laverty, D., Sweeney, P., Filbet, M., Newbold, K., De Andrés, J., & Mercadante, S. (2010). Salivary gland dysfunction ('dry mouth’) in patients with cancer: A consensus statement. European Journal of Cancer Care, 19(2), 172–177. https://doi.org/10.1111/j.1365-2354.2009.01081.x

Davies, A., & Hall, S. (2011). Salivary gland dysfunction (dry mouth) in patients with advanced cancer. International Journal of Palliative Nursing, 17(10), 477–482. https://doi.org/10.12968/ijpn.2011.17.10.477

Fleming, M., Craigs, C. L., & Bennett, M. I. (2020). Palliative care assessment of dry mouth: what matters most to patients with advanced disease? Supportive Care in Cancer, 28(3),1121–1129. https://doi.org/10.1007/s00520-019-04908-9

Kahn, S. T., & Johnstone, P. A. S. (2005). Management of xerostomia related to radiotherapy for head and neck cancer. Oncology (Williston Park, N.Y.), 19(14).

Kvalheim, S. F., Marthinussen, M. C., Haugen, D. F., Berg, E., Strand, G. V., & Lie, S. A. (2019). Randomized controlled trial of the effectiveness of three different oral moisturizers in palliative care patients. European Journal of Oral Sciences, 127(6), 523–530. https://doi.org/10.1111/eos.12655

Lopez, G., Garcia, M. K., Liu, W., Spano, M., Underwood, S., Dibaj, S. S., Li, Y., Moguel, R., Williams, J., Bruera, E., & Cohen, L. (2018). Outpatient acupuncture effects on patient self-reported symptoms in oncology care: A retrospective analysis. Journal of Cancer, 9(19), 3613–3619. https://doi.org/10.7150/jca.26527

Lourenço, R. S. P. (2017). Xerostomia e qualidade de vida: tradução e validação da xerostomia related quality of life scale (XeQoLS) para a população portuguesa de cuidados paliativos. http://hdl.handle.net/10451/33971

Meidell, L., & Holritz Rasmussen, B. (2009). Acupuncture as an optional treatment for hospice patients with xerostomia: an intervention study. International Journal of Palliative Nursing, 15(1), 12–20. https://doi.org/10.12968/ijpn.2009.15.1.37947

Mercadante, S., Calderone, L., Villari, P., Serretta, R., Sapio, M., Casuccio, A., & Fulfaro, F. (2000). The use of pilocarpine in opioid-induced xerostomia. Palliative Medicine, 14(6), 529–531. https://doi.org/10.1191/026921600701536273

Mercadante, S., Aielli, F., Adile, C., Ferrera, P., Valle, A., Fusco, F., ... & Porzio, G. (2015). Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Supportive Care in Cancer, 23(11), 3249-3255. doi:10.1007/s00520-015-2720-y

Montgomery-Cranny, J., Hodgson, T., & Hegarty, A. M. (2014). Aetiology and management of xerostomia and salivary gland hypofunction. British Journal of Hospital Medicine, 75(9), 509-514. doi: dx.doi.org/10.12968/hmed.2014.75.9.509

Moore, P. A., & Guggenheimer, J. (2008). Medication-induced hyposalivation: etiology, diagnosis, and treatment. Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995), 29(1), 50–55.

Mortazavi, H., Baharvand, M., Movahhedian, A., Mohammadi, M., & Khodadoustan, A. (2014). Xerostomia due to systemic disease: a review of 20 conditions and mechanisms. Annals of medical and health sciences research, 4(4), 503-510. doi:10.4103/2141-9248.139284

Nieuw Amerongen, A. V., & Veerman, E. C. I. (2003). Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Supportive Care in Cancer, 11(4), 226–231. https://doi.org/10.1007/s00520-002-0409-5

Peters M.D.J., Godfrey C, McInerney P, Munn Z, Tricco AC, & Khalil, H (2020). Chapter 11: Scoping Reviews. In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis, JBI. https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-12

Plemons, .J. M., Al-Hashimi, I., & Marek, C. L. (2014). American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc.(8):867-73. doi: 10.14219/jada.2014.44. PMID: 25082939.

Reisfield, G. M., Rosielle, D. A., & Wilson, G. R. (2009). Xerostomia, second edition #182. Journal of Palliative Medicine, 12(2), 189–190. https://doi.org/10.1089/jpm.2009.9670

Sheehy, L. (2013). Understanding Factors that influence the grieving process. End of Life Journal, 3(1), 1–9. https://doi.org/10.1136/eoljnl-03-01.1

Sweeney, M. P., Bagg, J., Baxter, W. P., & Aitchison, T. C. (1997). Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliative Medicine, 11(3), 225–232. https://doi.org/10.1177/026921639701100307

Towler, P., Molassiotis, A., & Brearley, S. G. (2013). What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: An integrative overview of reviews. Supportive Care in Cancer, 21(10), 2913–2923. https://doi.org/10.1007/s00520-013-1882-8

Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., & Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850

Twycross, R. (2020). Interview with Dr. Robert Twycross, DM Oxon, FRCP, FRCR, Emeritus Clinical Reader in Palliative Medicine, Oxford University, Oxford, UK by WMJ Editor Peteris Apinis In World Medical Journal. Official Journal of The World Medical Association. Nr.1, vol. 66 ajnuary 2020

World Health Organization (WHO) (2014). Executive Board. Strengthening of palliative care as a component of integrated treatment within the continuum of care [Internet]. Geneve. http://apps.who.int/gb/ebwha/pdf_files/EB134/ B134_R7-en.pdf 30

Worldwide Hospice Palliative Care Alliance (WHPCA) (2020). Global Atlas of Palliative Care. 2nd Edition. ISBN: 978-0-9928277-2-4. http://www.thewhpca.org/resources/global

Venkatasalu, M. R., Murang, Z. R., Ramasamy, D. T. R., & Dhaliwal, J. S. (2020). Oral health problems among palliative and terminally ill patients: An integrated systematic review. BMC Oral Health, 20(1), 1–11. https://doi.org/10.1186/s12903-020-01075-w

Descargas

Publicado

2022-05-31

Cómo citar

Lourenço, M., Cunha, S. ., Fernandes, O. ., Silva, P., & Oliveira, S. (2022). intervenciones en el control de la xerostomia en persona en situación paliativa : revisión de alcance. Millenium - Journal of Education, Technologies, and Health, 2(18), 51–63. https://doi.org/10.29352/mill0218.26797

Número

Sección

Ciencias de la Vida y de la Salud